Conditions: Healthy Volunteers
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 11
Healthy volunteers: yes

Brief summary:
The main purpose of this study is to evaluate how the body processes the study drug known as insulin peglispro and how the study drug affects blood sugar in healthy male Japanese participants. This study will also evaluate safety of the study drug. The study will last up to 46 days for each participant, not including screening.

Detailed description:

Arms:
arm 1: Single subcutaneous dose of 1.3 Units per kilogram (U/kg) insulin peglispro on Day 1.

Interventions: intervention 1: Insulin Peglispro
Intervention descriptions: intervention 1: None

Protocol document: